-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lyra Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2019 to Q3 2024.
- Lyra Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.4M, a 26.1% increase year-over-year.
- Lyra Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$101M, a 54.1% decline year-over-year.
- Lyra Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$67.1M, a 19.2% decline from 2022.
- Lyra Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$56.3M, a 29.1% decline from 2021.
- Lyra Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$43.6M, a 96.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)